Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-047359
Filing Date
2025-03-05
Accepted
2025-03-05 17:27:09
Documents
20
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 d908936ds8.htm S-8 54816
2 EX-5.1 d908936dex51.htm EX-5.1 7963
3 EX-23.2 d908936dex232.htm EX-23.2 1834
4 EX-99.1 d908936dex991.htm EX-99.1 53332
5 EX-99.2 d908936dex992.htm EX-99.2 55373
6 EX-99.3 d908936dex993.htm EX-99.3 66464
7 EX-FILING FEES d908936dexfilingfees.htm   iXBRL EX-FILING FEES 34707
8 GRAPHIC g908936dsp_1.jpg GRAPHIC 10936
9 GRAPHIC g908936g0303185748733.jpg GRAPHIC 3781
  Complete submission text file 0001193125-25-047359.txt   445190

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d908936dexfilingfees_htm.xml XML 12763
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285585 | Film No.: 25712550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)